Standardization in cell therapy industry is a race against time

Accellerate Summit highlights needs and challenges in standardization

Industry stakeholders propose unified CAR T toxicity grading scale

CIBMTR Cellular Therapy Registry recommended to meet outcomes data reporting requirements

Advancements in Cell Therapy: 2018 Year-In-Review

As CAR-T therapies mature, researchers begin to track long-term patient outcomes